These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2285657)

  • 1. Effects of ketanserin on intraocular pressure.
    Costagliola C; Fasano ML; Iuliano G; Ferrara LA
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():97-9. PubMed ID: 2285657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ketanserin administration on intraocular pressure.
    Tekat D; Güler C; Arici M; Topalkara A; Erdoğan H
    Ophthalmologica; 2001; 215(6):419-23. PubMed ID: 11741108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
    Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
    PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral ketanserin administration on intraocular pressure in glaucomatous patients.
    Costagliola C; Scibelli G; Fasano ML; Ferrara LA; Mastropasqua L
    Exp Eye Res; 1991 May; 52(5):507-10. PubMed ID: 2065721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of topical ketanserin administration on intraocular pressure.
    Costagliola C; Iuliano G; Rinaldi M; Russo V; Scibelli G; Mastropasqua L
    Br J Ophthalmol; 1993 Jun; 77(6):344-8. PubMed ID: 8318480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.
    Diestelhorst M
    Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):433-9. PubMed ID: 10901475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol.
    Konstas AG; Pikilidou MI; Tsironi S; Mikropoulos D; Kozobolis VP; Sarafidis PA; Lasaridis AN; Nelson LA; Stewart WC
    Curr Eye Res; 2009 May; 34(5):369-77. PubMed ID: 19401880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma.
    Realini TD
    Ophthalmology; 2009 Jul; 116(7):1237-42. PubMed ID: 19576495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucoma.
    Gandolfi S; Paredes T; Goldberg I; Coote M; Wells A; Volksone L; Pillai MR; Stalmans I; Denis P;
    Eur J Ophthalmol; 2012; 22(1):34-44. PubMed ID: 22167541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The one-eye trial and fellow eye response to prostaglandin analogues.
    Dayanir V; Cakmak H; Berkit I
    Clin Exp Ophthalmol; 2008 Mar; 36(2):136-41. PubMed ID: 18352869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel dopamine D-1 antagonist and D-2 agonist, SDZ GLC-756, lowers intraocular pressure in healthy human volunteers and in patients with glaucoma.
    Prünte C; Flammer J
    Ophthalmology; 1995 Sep; 102(9):1291-7. PubMed ID: 9097765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of locally produced Latanoprost in the control of intraocular pressure in patients with primary open-angle glaucoma.
    Mahar PS; Butt NH; Ali SI
    Int Ophthalmol; 2018 Dec; 38(6):2593-2597. PubMed ID: 29209880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertension.
    Franks W;
    Curr Med Res Opin; 2006 Sep; 22(9):1643-9. PubMed ID: 16968567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma.
    Ishibashi S; Hirose N; Tawara A; Kubota T
    J Glaucoma; 2006 Oct; 15(5):354-7. PubMed ID: 16988595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertension.
    Gandolfi SA; Lim J; Sanseau AC; Parra Restrepo JC; Hamacher T
    Adv Ther; 2014 Dec; 31(12):1213-27. PubMed ID: 25430900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension.
    Katsanos A; Dastiridou AI; Fanariotis M; Kotoula M; Tsironi EE
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):67-71. PubMed ID: 21214361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.
    Diestelhorst M; Larsson LI;
    Br J Ophthalmol; 2004 Feb; 88(2):199-203. PubMed ID: 14736774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of pneumatic traheculoplasty (PNT) in patients with open angle glaucoma and ocular hypertension--a preliminary report].
    Wierzbowska J; Stankiewicz A; Romańska Ł
    Klin Oczna; 2008; 110(7-9):287-91. PubMed ID: 19112863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma.
    Hayashi K; Yoshida M; Manabe SI; Yoshimura K
    Ophthalmology; 2017 May; 124(5):701-708. PubMed ID: 28110949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
    Weinreb RN; Scassellati Sforzolini B; Vittitow J; Liebmann J
    Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.